Gliapharm SA

GLIAPHARM

The mark consists of two intersecting circles with a continual line running through both circles. The lighter shaded circle stands on the right and upper side, while the darker shaded circle stands on the left and lower side. The lighter shaded circle has a line crossing through the center of the continual line. The darker shaded circle adds an additional line to create a checkmark design at the bottom of the continual line. The stylized wording GLIAPHARM is shown underneath the circles, with the element GLIA appearing in a darker shade.;Biological preparations for the prevention and treatment of neurological diseases; pharmaceutical preparations for the prevention and treatment of neurological diseases; chemical preparations for the prevention and treatment of neurological diseases; pharmaceutical products for the prevention and treatment of neurological diseases; medicines for the prevention and treatment of neurological diseases; diagnostic preparations for medical use; biomarking diagnostic reagents for medical use; plant extracts for pharmaceutical use;GLIA PHARM;Color is not claimed as a feature of the mark.;Clinical trials, scientific laboratory services, biological research, scientific research, research and development of new products for others, chemical research;